TN2009000278A1 - 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses - Google Patents
3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responsesInfo
- Publication number
- TN2009000278A1 TN2009000278A1 TNP2009000278A TN2009000278A TN2009000278A1 TN 2009000278 A1 TN2009000278 A1 TN 2009000278A1 TN P2009000278 A TNP2009000278 A TN P2009000278A TN 2009000278 A TN2009000278 A TN 2009000278A TN 2009000278 A1 TN2009000278 A1 TN 2009000278A1
- Authority
- TN
- Tunisia
- Prior art keywords
- treatment
- compounds
- substituted
- synaptic responses
- glutamatergic synaptic
- Prior art date
Links
- -1 3-substituted-[1,2,3] benzotriazinone compounds Chemical class 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000000848 glutamatergic effect Effects 0.000 title 1
- 230000009782 synaptic response Effects 0.000 title 1
- 210000004556 brain Anatomy 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000003930 cognitive ability Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010027175 memory impairment Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 210000000225 synapse Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pest Control & Pesticides (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Agronomy & Crop Science (AREA)
- Psychology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87862607P | 2007-01-03 | 2007-01-03 | |
| PCT/US2007/026415 WO2008085505A1 (fr) | 2007-01-03 | 2007-12-28 | Composés [1,2,3]benzotriazinone substitués en position 3 destinés à améliorer les réponses synaptiques glutamatergiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2009000278A1 true TN2009000278A1 (en) | 2010-10-18 |
Family
ID=39608955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2009000278A TN2009000278A1 (en) | 2007-01-03 | 2009-06-30 | 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20100041647A1 (fr) |
| EP (1) | EP2114158B1 (fr) |
| JP (1) | JP2010514837A (fr) |
| KR (1) | KR20090098999A (fr) |
| CN (1) | CN101626686A (fr) |
| AP (1) | AP2009004915A0 (fr) |
| AR (1) | AR064739A1 (fr) |
| AU (1) | AU2007342364A1 (fr) |
| BR (1) | BRPI0720323A2 (fr) |
| CA (1) | CA2674321A1 (fr) |
| CO (1) | CO6210740A2 (fr) |
| CR (1) | CR10913A (fr) |
| EA (1) | EA200900937A1 (fr) |
| EC (1) | ECSP099538A (fr) |
| IL (1) | IL199662A0 (fr) |
| MA (1) | MA31159B1 (fr) |
| MX (1) | MX2009007209A (fr) |
| NZ (1) | NZ578290A (fr) |
| TN (1) | TN2009000278A1 (fr) |
| WO (1) | WO2008085505A1 (fr) |
| ZA (1) | ZA200905065B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE527269T1 (de) * | 2007-01-03 | 2011-10-15 | Cortex Pharma Inc | 3-substituierte ä1,2,3ü-benzotriazinonverbindung zur förderung der glutamatergen synapsenreaktionen |
| JP5694765B2 (ja) * | 2007-05-17 | 2015-04-01 | コーテックス ファーマシューティカルズ， インコーポレイテッド | グルタミン酸作動性シナプス反応を増強するための二置換アミド |
| US8168632B2 (en) | 2007-08-10 | 2012-05-01 | Cortex Pharmaceuticals, Inc. | Bicyclic amide derivatives for the treatment of respiratory disorders |
| RU2010106975A (ru) | 2007-08-10 | 2011-09-20 | Кортекс Фармасьютикалз, Инк. (Us) | Бициклические амиды для усиления глутаматергических синаптических ответов |
| MX2010002890A (es) * | 2007-09-20 | 2010-07-02 | Cortex Pharma Inc | 1, 2, 3-triacin -4-onas sustituidas en la posicion 3 y 1, 3- pirimidinonas sustituidas en la posicion 3 para mejorar las respuestas sinapticas glutamatergicas. |
| US20110257186A1 (en) | 2010-04-15 | 2011-10-20 | Staubli Ursula V | Compositions and methods for treating visual disorders |
| EP3485882A1 (fr) | 2013-01-25 | 2019-05-22 | Case Western Reserve University | Compositions pour le traitement de troubles envahissants du développement |
| CN105418525B (zh) * | 2015-12-16 | 2017-12-15 | 郑州轻工业学院 | 一种n‑取代1,2,3‑苯并三嗪‑4‑酮的制备方法 |
| CN114716416B (zh) * | 2022-04-11 | 2023-06-16 | 湖北大学 | 3,4-二氢吡咯衍生物及其一锅法合成 |
| KR20240142302A (ko) * | 2023-03-21 | 2024-09-30 | 주식회사 비보존 | mGluR5 및 HDAC6의 이중 조절제 및 이의 용도 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3723436A (en) * | 1971-02-25 | 1973-03-27 | Sun Oil Co | Process for aromatic lactams |
| FR2597103B1 (fr) * | 1986-04-15 | 1988-12-16 | Provesan Sa | Procede de preparation de derives d'oxazinobenzothiazine 6,6-dioxyde |
| GB9202915D0 (en) * | 1992-02-12 | 1992-03-25 | Wellcome Found | Chemical compounds |
| KR100303523B1 (ko) * | 1992-07-24 | 2001-11-22 | 린다 에스. 스티븐슨 | Ampa수용체에의해중재되는시냅스반응을증진하는약제 |
| US5962477A (en) * | 1994-04-12 | 1999-10-05 | Adolor Corporation | Screening methods for cytokine inhibitors |
| US5650409A (en) * | 1995-06-02 | 1997-07-22 | Cortex Pharmaceuticals, Inc. | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| US5736543A (en) * | 1996-04-03 | 1998-04-07 | The Regents Of The University Of California | Benzoxazines for enhancing synaptic response |
| AU4416197A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Positive ampa receptor modulation to enhance brain neurotrophic factor expression |
| US6110935A (en) * | 1997-02-13 | 2000-08-29 | The Regents Of The University Of California | Benzofurazan compounds for enhancing glutamatergic synaptic responses |
| US5985871A (en) * | 1997-12-24 | 1999-11-16 | Cortex Pharmaceuticals, Inc. | Benzoxazine compounds for enhancing synaptic response |
| US6713474B2 (en) * | 1998-09-18 | 2004-03-30 | Abbott Gmbh & Co. Kg | Pyrrolopyrimidines as therapeutic agents |
| US6303542B1 (en) * | 2000-08-18 | 2001-10-16 | Rohm And Haas Company | Herbicidal 3-substituted-phenyl-1,2,3-benzotriazin-4-ones |
| MXPA04004815A (es) * | 2001-11-26 | 2005-02-17 | Cortex Pharma Inc | Compuestos de carbonilbenzoxazina para mejorar respuestas sinapticas, glutamatergicas. |
| AUPS255202A0 (en) * | 2002-05-27 | 2002-06-13 | Monash University | Agents and methods for the treatment of disorders associated with motor neuron degeneration |
| DE10238865A1 (de) * | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| GB0317482D0 (en) * | 2003-07-25 | 2003-08-27 | Pfizer Ltd | Nicotinamide derivatives useful as pde4 inhibitors |
| CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
| ATE527269T1 (de) * | 2007-01-03 | 2011-10-15 | Cortex Pharma Inc | 3-substituierte ä1,2,3ü-benzotriazinonverbindung zur förderung der glutamatergen synapsenreaktionen |
| JP5694765B2 (ja) * | 2007-05-17 | 2015-04-01 | コーテックス ファーマシューティカルズ， インコーポレイテッド | グルタミン酸作動性シナプス反応を増強するための二置換アミド |
| MX2010002890A (es) * | 2007-09-20 | 2010-07-02 | Cortex Pharma Inc | 1, 2, 3-triacin -4-onas sustituidas en la posicion 3 y 1, 3- pirimidinonas sustituidas en la posicion 3 para mejorar las respuestas sinapticas glutamatergicas. |
-
2007
- 2007-12-28 CN CN200780051958A patent/CN101626686A/zh active Pending
- 2007-12-28 BR BRPI0720323A patent/BRPI0720323A2/pt not_active IP Right Cessation
- 2007-12-28 JP JP2009544856A patent/JP2010514837A/ja active Pending
- 2007-12-28 KR KR1020097015941A patent/KR20090098999A/ko not_active Ceased
- 2007-12-28 EA EA200900937A patent/EA200900937A1/ru unknown
- 2007-12-28 WO PCT/US2007/026415 patent/WO2008085505A1/fr not_active Ceased
- 2007-12-28 MX MX2009007209A patent/MX2009007209A/es not_active Application Discontinuation
- 2007-12-28 US US12/448,770 patent/US20100041647A1/en not_active Abandoned
- 2007-12-28 CA CA002674321A patent/CA2674321A1/fr not_active Abandoned
- 2007-12-28 EP EP07868092A patent/EP2114158B1/fr active Active
- 2007-12-28 AU AU2007342364A patent/AU2007342364A1/en not_active Abandoned
- 2007-12-28 AP AP2009004915A patent/AP2009004915A0/xx unknown
- 2007-12-28 NZ NZ578290A patent/NZ578290A/en not_active IP Right Cessation
-
2008
- 2008-01-03 AR ARP080100021A patent/AR064739A1/es not_active Application Discontinuation
-
2009
- 2009-06-30 TN TNP2009000278A patent/TN2009000278A1/fr unknown
- 2009-07-02 IL IL199662A patent/IL199662A0/en unknown
- 2009-07-03 CR CR10913A patent/CR10913A/es not_active Application Discontinuation
- 2009-07-14 CO CO09072923A patent/CO6210740A2/es not_active Application Discontinuation
- 2009-07-20 ZA ZA200905065A patent/ZA200905065B/xx unknown
- 2009-07-23 EC EC2009009538A patent/ECSP099538A/es unknown
- 2009-07-31 MA MA32133A patent/MA31159B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2009004915A0 (en) | 2009-08-31 |
| NZ578290A (en) | 2012-03-30 |
| CR10913A (es) | 2009-09-21 |
| CN101626686A (zh) | 2010-01-13 |
| EP2114158A4 (fr) | 2010-05-05 |
| ZA200905065B (en) | 2010-04-28 |
| MX2009007209A (es) | 2009-10-12 |
| EA200900937A1 (ru) | 2009-12-30 |
| EP2114158A1 (fr) | 2009-11-11 |
| KR20090098999A (ko) | 2009-09-18 |
| AR064739A1 (es) | 2009-04-22 |
| EP2114158B1 (fr) | 2012-08-08 |
| IL199662A0 (en) | 2010-04-15 |
| MA31159B1 (fr) | 2010-02-01 |
| BRPI0720323A2 (pt) | 2016-08-09 |
| CA2674321A1 (fr) | 2008-07-17 |
| US20100041647A1 (en) | 2010-02-18 |
| CO6210740A2 (es) | 2010-10-20 |
| AU2007342364A1 (en) | 2008-07-17 |
| JP2010514837A (ja) | 2010-05-06 |
| ECSP099538A (es) | 2009-12-28 |
| WO2008085505A1 (fr) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000278A1 (en) | 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses | |
| SG163545A1 (en) | 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses | |
| EP2340242A4 (fr) | Composés de traitement de maladies et troubles ophtalmiques | |
| EA201390971A1 (ru) | ИМИДАЗО[5,1-f][1,2,4]ТРИАЗИНЫ ДЛЯ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ | |
| BRPI0817271A2 (pt) | Método de tratamento da doença de parkinson e outros distúrbios relacionados | |
| MY148558A (en) | Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use | |
| EP2076124A4 (fr) | Composés dérivés de styrényle pour traiter des maladies et des troubles ophtalmiques | |
| GB2463833A (en) | Methods and compositions for the treatment of neurological disorders | |
| WO2008050341A3 (fr) | Agents psychotropes innovants présentant une activité du glutamate sur les récepteurs nmda | |
| MX2012010658A (es) | Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa. | |
| NO20082923L (no) | Anvendelse av en CB1 antagonist for behandling av bivirkninger og negative symptomer pa schizofreni | |
| EP2152865A4 (fr) | Méthodes de traitement et de prévention de maladies et de troubles neurodégénératifs | |
| WO2013029060A3 (fr) | Compositions et méthodes de traitement de maladies neurodégénératives | |
| EP2750606A4 (fr) | Méthodes de diagnostic et de traitement de maladies et d'affections neurologiques et neurodégénératives et procédés associés | |
| JP2009537568A5 (fr) | ||
| WO2003045315A3 (fr) | Composes carbonylbenzoxaziniques ameliorant les reponses synaptiques glutamatergiques | |
| UA93306C2 (ru) | Соединение 3-замещенного-[1,2,3]-бензотриазинона для улучшения глутаматергических синаптических реакций | |
| EP2552473A4 (fr) | Méthodes de traitement de la maladie de parkinson et autres troubles des neurones dopaminergiques du cerveau | |
| WO2007034326A3 (fr) | Composes imidazoles pour le traitement de troubles neurologiques | |
| WO2011015646A3 (fr) | Dérivés de furane-imidazolone pour le traitement de maladies ou troubles cognitifs, neurodégénératifs ou neuronaux | |
| MX2011008060A (es) | Derivados de amida biciclica para mejorar las respuestas sinapticas glutamatergicas. | |
| Hirano | The use of 40 Hz-ASR can predict conscious outcome in patients with severe head injury in the early stage | |
| HK1140209B (en) | Receptor modulators exhibiting neuroprotective and memory enhancing activities | |
| HK1173654A1 (zh) | 治疗化合物及相关的使用方法 | |
| HK1148234A (en) | Device and method for treating central nervous system pathology |